Legal Services

Over 1 million children in Afghanistan are severely malnourished — and the numbers are rising. With drought, conflict, and forced deportations worsening the crisis, families are struggling to survive. Discover how humanitarian aid is fighting back — and why more support is urgently needed.

Bayer’s Eylea™ 8mg is now approved in the UK and Korea for macular edema caused by retinal vein occlusion — its third indication in both markets. With longer dosing intervals and global biosimilar competition heating up, this approval signals a new era for eye care. Here’s what you need to know.

The FDA just approved Dupixent® for allergic fungal rhinosinusitis — the first and only treatment for this condition in the U.S. Meanwhile, biosimilar developers from Alvotech to Samsung Bioepis are accelerating their pipelines. Here’s what this means for patients, pharma, and the future of biologics.

Poland’s president vetoed a key law aligning the country with the EU’s Digital Services Act — claiming it threatens free speech. But experts say the real danger? Leaving users, especially children, exposed to illegal content with no recourse. Here’s why this veto misses the mark — and what’s at stake.

A major lawsuit targeting the U.S. government’s handling of employment-based and investor green cards has sparked concern among immigrants in 2026. With claims of arbitrary denials and processing delays, the case could significantly impact future immigration pathways. Learn what’s at stake and how to protect your status.

The U.S. healthcare landscape is evolving rapidly with new executive actions, regulatory changes, and political debates shaping the future of access, affordability, and innovation. From Trump’s push for drug price reform to FDA initiatives on rare disease treatments and federal AI safety concerns, key developments are set to impact patients, providers, and insurers alike.

From a teacher who got hired… then ghosted… to a prison guard fired for falling asleep — only to win big because her white coworkers got away with the same thing — these are the wild, true stories from 35 years of employment law. No legal jargon. Just real people, real drama, and the lessons every employee (and employer) needs to know.

Financial expert witnesses don't just crunch numbers — they navigate complex legal battles, defend their findings under pressure, and help courts understand what happened with millions of dollars at stake. Here are the lessons I've learned, the cases that changed how I work, and what attorneys need to know before hiring an expert.